Back to PE Pentwater Capital Management LP
PTGX
2 quarters
Position history for PEPentwater Capital Management LP's holdings in PROTAGONIST THERAPEUTICS INC
No. Pentwater Capital Management exited its PTGX (Protagonist Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 50,000 shares worth $4.4M. Pentwater Capital Management first reported PTGX in Q4 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$4.4M
Total Shares Change
-50,000
Quarter-by-Quarter History